14.60
price up icon5.19%   0.72
after-market Dopo l'orario di chiusura: 14.60
loading

Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
1.634 0.119 0.03 0.017
Operating Expenses
17.90%
73.83
89.92 45.95 41.37 43.78
Operating Income/Loss
16.38%
-73.83
-88.29 -45.83 -41.34 -43.77
Nonoperating Income/Loss
32.56%
-4.885
-3.685 -5.96 -5.708 -5.15
Income/Loss From Continuing Operations Before Tax
14.42%
-78.71
-91.97 -51.79 -47.05 -48.92
Income Tax Expense/Benefit
100.00%
-
-0.004 0.002 0.005 -
Income/Loss From Continuing Operations After Tax
14.42%
-78.71
-91.97 -51.79 -47.05 -48.92
Net Income/Loss
15.91%
-78.71
-93.60 -51.79 -47.05 -48.92
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,244%
54.55
2.327 47.15 43.64 43.58
Diluted Average Shares
2,244%
54.55
2.327 47.15 43.64 43.58
Basic Earnings Per Share
20.88%
-1.44
-1.82 -1.10 -1.08 -1.12
Diluted Earnings Per Share
20.88%
-1.44
-1.82 -1.10 -1.08 -1.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):